Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,679 public trials 158 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background Inclusive

NCT00800683

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • 1218.43.10027 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • 1218.43.10011 Boehringer Ingelheim Investigational Site Chula Vista, California, United States
  • 1218.43.10006 Boehringer Ingelheim Investigational Site Riverside, California, United States
  • 1218.43.10021 Boehringer Ingelheim Investigational Site Whittier, California, United States
View all 53 locations
View Trial Details
Completed

Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes

NCT01512979

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • 1218.83.11002 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • 1218.83.11036 Boehringer Ingelheim Investigational Site Little Rock, Arkansas, United States
  • 1218.83.11011 Boehringer Ingelheim Investigational Site Chino, California, United States
  • 1218.83.11001 Boehringer Ingelheim Investigational Site Huntington Beach, California, United States
View all 82 locations
View Trial Details
Completed

Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study

NCT00949286

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • LCC 80 - Canberra Hospital Garran, Australian Capital Territory, Australia
  • LCC 28 - Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • LCC 48 - Gosford Gosford, New South Wales, Australia
  • LCC 59 - Liverpool Hospital Liverpool, New South Wales, Australia
View all 172 locations
View Trial Details
Completed

Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg Bid

NCT00915772

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • 1218.52.11005 Boehringer Ingelheim Investigational Site Calgary, Alberta, Canada
  • 1218.52.11003 Boehringer Ingelheim Investigational Site Edmonton, Alberta, Canada
  • 1218.52.11002 Boehringer Ingelheim Investigational Site Red Deer, Alberta, Canada
  • 1218.52.11006 Boehringer Ingelheim Investigational Site Vancouver, British Columbia, Canada
View all 112 locations
View Trial Details

Related conditions